TrialBMC cancer2021

A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.

Seonggyu Byeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.